Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Angiotensin-independent mechanism for aldosterone synthesis during chronic extracellular fluid volume depletion.
S Okubo, … , T Matsusaka, I Ichikawa
S Okubo, … , T Matsusaka, I Ichikawa
Published March 1, 1997
Citation Information: J Clin Invest. 1997;99(5):855-860. https://doi.org/10.1172/JCI119249.
View: Text | PDF
Research Article Article has an altmetric score of 3

Angiotensin-independent mechanism for aldosterone synthesis during chronic extracellular fluid volume depletion.

  • Text
  • PDF
Abstract

Wild-type (Agt+/+) and homozygous angiotensinogen deletion mutant (Agt-/-) littermates were placed on normal (NS) or low Na diet (LS) for 2 weeks. Plasma aldosterone levels (P(aldo)) were comparable during NS, and similarly elevated during LS in Agt+/+ and Agt-/-. Moreover, in both, the elevation in P(aldo) was accompanied by marked increase in adrenal zona glomerulosa cells and adrenal P450aldo mRNA. Agt-/- mice were distinguished from Agt+/+ mice by their higher plasma K level, by approximately 1.5 and approximately 3.8 mEq/liter during NS and LS, respectively. Within the Agt-/- group, P(aldo) was directly proportional to plasma K. The importance of K for the hyperaldosteronism during dietary Na restriction was verified by the observation that superimposition of K restriction led to hypotension in Agt+/+ and uniform death in Agt-/- mice along with a reduction in P(aldo) by 75 and 90%, respectively. Thus, suppression of potassium, but not angiotensin, led to a marked attenuation of hyperaldosteronism during dietary Na restriction. Therefore, (a) a powerful angiotensin-independent mechanism exists for the hyperaldosteronism during LS; (b) high K is a central component of this mechanism; (c) contrary to current belief, the tonic effect of high K on aldosterone synthesis and release does not require an intact renin-angiotensin system; and (d) normally, intermediary feedback signals for hyperaldosteronism, i.e., both hypotension and high K, are effectively masked by aldosterone actions.

Authors

S Okubo, F Niimura, H Nishimura, F Takemoto, A Fogo, T Matsusaka, I Ichikawa

×

Total citations by year

Year: 2025 2024 2022 2021 2020 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1956 Total
Citations: 2 3 1 2 1 1 2 1 1 1 1 8 9 2 5 5 4 4 9 4 5 6 14 9 5 1 106
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (106)

Title and authors Publication Year
Impaired aldosterone response to potassium and hyperkalemia in patients receiving a renin-angiotensin-aldosterone system inhibitor
Kim M, Lee HY, Kim H
The Korean Journal of Internal Medicine 2025
Discontinuing renin-angiotensin system inhibitors after incident hyperkalemia and clinical outcomes: target trial emulation.
Hashimoto N, Sakaguchi Y, Hattori K, Kawano Y, Kawaoka T, Doi Y, Oka T, Kusunoki Y, Yamamoto S, Yamato M, Yamamoto R, Matsui I, Mizui M, Kaimori JY, Isaka Y
Hypertension research : official journal of the Japanese Society of Hypertension 2025
The renin angiotensin aldosterone system.
Triebel H, Castrop H
2024
Control of sodium appetite by hindbrain aldosterone-sensitive neurons
Kuralay A, McDonough MC, Resch JM
Molecular and cellular endocrinology 2024
Aldosterone-induced salt appetite requires HSD2 neurons
Silvia Gasparini, Lila Peltekian, Miriam C. McDonough, Chidera J. A. Mitchell, Marco Hefti, Jon M Resch, Joel C. Geerling
JCI Insight 2024
Aldosterone-Regulated Sodium Transport and Blood Pressure
Tsilosani A, Gao C, Zhang W
Frontiers in physiology 2022
Despite increasing aldosterone, elevated potassium is not necessary for activating aldosterone‐sensitive HSD2 neurons or sodium appetite
FS Fazan, E Colombari, AD Loewy, JC Geerling
Physiological Reports 2021
Signal Transduction of Mineralocorticoid and Angiotensin II Receptors in the Central Control of Sodium Appetite: A Narrative Review
M Iovino, T Messana, G Lisco, A Vanacore, VA Giagulli, E Guastamacchia, GD Pergola, V Triggiani
International journal of molecular sciences 2021
ENaC in Salt-Sensitive Hypertension: Kidney and Beyond
AL Pitzer, JP Beusecum, TR Kleyman, A Kirabo
Current Hypertension Reports 2020
Reference Module in Neuroscience and Biobehavioral Psychology
NE Straznicky, EA Lambert, GW Lambert, MD Esler
Reference Module in Neuroscience and Biobehavioral Psychology 2017
Endocrinology: Adult and Pediatric
M Gurnell, TJ Visser, P Beck-Peccoz, VK Chatterjee
Endocrinology: Adult and Pediatric 2016
Endocrinology
C Napier, SH Pearce
Endocrinology 2016
Determinants of water and sodium intake and output
AE Stanhewicz, WL Kenney
Nutrition Reviews 2015
Mineralocorticoid-Induced Sodium Appetite and Renal Salt Retention: Evidence for Common Signaling and Effector Mechanisms
Y Fu, V Vallon
Nephron Physiology 2014
Seldin and Giebisch's The Kidney
CJ Cooper, LD Dworkin, WL Henrich
Seldin and Giebisch's The Kidney 2013
ARB protects podocytes from HIV-1 nephropathy independently of podocyte AT1
A Shimizu, J Zhong, Y Miyazaki, T Hosoya, I Ichikawa, T Matsusaka
Nephrology Dialysis Transplantation 2012
Acute and Chronic Regulation of Aldosterone Production
NG Hattangady, LO Olala, WB Bollag, WE Rainey
Molecular and Cellular Endocrinology 2011
Conservation of Na+ vs. K+ by the rat cortical collecting duct
G Frindt, V Houde, LG Palmer
AJP Renal Physiology 2011
Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease
JP Bertocchio, DG Warnock, F Jaisser
Kidney International 2011
Mineralocorticoid-receptor Antagonists in Heart Failure: A Tale of Serendipity and Success
A Reyentovich, SD Katz
Current Heart Failure Reports 2011
Plasma aldosterone levels in patients with coronary artery disease without heart failure or myocardial infarction: implications for pathophsiology, prognosis, and therapy
B Pitt
European Heart Journal 2011
Mineralocorticoid receptor antagonists for heart failure
AM Richards
Expert Opinion on Pharmacotherapy 2011
The Role of Mineralocorticoid Receptor Antagonists in Patients with American College of Cardiology/American Heart Association StageB Heart Failure
B Pitt
Heart Failure Clinics 2011
Conservation of Na + vs. K + by the rat cortical collecting duct
G Frindt, V Houde, LG Palmer
American journal of physiology. Renal physiology 2011
Minireview: Aldosterone and Mineralocorticoid Receptors: Past, Present, and Future
JW Funder
Endocrinology 2010
Blocking the RAAS at different levels: an update on the use of the direct renin inhibitors alone and in combination
F Cagnoni, CA Njwe, A Zaninelli, AR Ricci, D Daffra, A D'Ospina, P Preti, M Destro
Vascular Health and Risk Management 2010
High-salt diet during pregnancy and angiotensin-related cardiac changes
Y Ding, J Lv, C Mao, H Zhang, A Wang, L Zhu, H Zhu, Z Xu
Journal of Hypertension 2010
Role of the renin-angiotensin-aldosterone system for control of arterial blood pressure following moderate deficit in total body sodium: Balance studies in freely moving dogs
E Seeliger, T Lunenburg, M Ladwig, HW Reinhardt
Clinical and Experimental Pharmacology and Physiology 2010
Aldosterone: A cardiovascular risk factor?
JW Funder, M Reincke
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2010
Executive Summary: HFSA 2010 Comprehensive Heart Failure Practice Guideline
HF America
Journal of Cardiac Failure 2010
Aldosterone and Mineralocorticoid Receptors in the Cardiovascular System
JW Funder
Progress in Cardiovascular Diseases 2010
Aldosterone Antagonists in Heart Failure
M Guglin, O Kristof-Kuteyeva, I Novotorova, P Pratap
Journal of cardiovascular pharmacology and therapeutics 2010
The Role of Aldosterone Blockade in Patients with Hypertensive Heart and Cardiovascular Disease
B Pitt
Clinical medicine insights. Therapeutics 2010
Dietary sodium deprivation evokes activation of brain regional neurons and down-regulation of angiotensin II type 1 receptor and angiotensin-convertion enzyme mRNA expression
B Lu, XJ Yang, K Chen, DJ Yang, JQ Yan
Neuroscience 2009
Long-Term Antiproteinuric Effect of Dual Renin-Angiotensin System Blockade
NR Robles, EF Carbonero, B Romero, ES Casado, JJ Cubero
Cardiovascular Therapeutics 2009
A novel adipokine CTRP1 stimulates aldosterone production
JH Jeon, K Kim, JH Kim, A Baek, H Cho, YH Lee, JW Kim, D Kim, SH Han, JS Lim, KI Kim, DY Yoon, SH Kim, GT Oh, E Kim, Y Yang
The FASEB Journal 2008
Aldosterone Breakthrough Caused by Chronic Blockage of Angiotensin II Type 1 Receptors in Human Adrenocortical Cells: Possible Involvement of Bone Morphogenetic Protein-6 Actions
H Otani, F Otsuka, K Inagaki, J Suzuki, T Miyoshi, Y Kano, J Goto, T Ogura, H Makino
Endocrinology 2008
Effect of Renin-Angiotensin-Aldosterone System Triple Blockade on Non-Diabetic Renal Disease: Addition of an Aldosterone Blocker, Spironolactone, to Combination Treatment with an Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker
Y FURUMATSU, Y NAGASAWA, K TOMIDA, S MIKAMI, T KANEKO, N OKADA, Y TSUBAKIHARA, E IMAI, T SHOJI
Hypertension Research 2008
Central regulation of sodium appetite: Central regulation of sodium appetite
JC Geerling, AD Loewy
Experimental Physiology 2008
Aldosterone Blockade in Patients with Chronic Heart Failure
B Pitt
Cardiology Clinics 2008
The Role of Aldosterone and Mineralocorticoid Receptors in Cardiovascular Disease
JW Funder
American Journal of Cardiovascular Drugs 2007
Aldosteron und Aldosteronrezeptorantagonisten in der Herzinsuffizienztherapie
T Rau, T Eschenhagen
Clinical Research in Cardiology Supplements 2007
Drospirenone for Oral Contraception and Hormone Replacement Therapy
A Motivala, B Pitt
Drugs 2007
Sodium depletion activates the aldosterone-sensitive neurons in the NTS independently of thirst
JC Geerling, AD Loewy
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2007
Drospirenone for Oral Contraception and Hormone Replacement Therapy: Are its Cardiovascular Risks and Benefits the Same as Other Progestogens?
A Motivala, B Pitt
Drugs 2007
Section 7: Heart Failure in Patients With Left Ventricular Systolic Dysfunction
HF America
Journal of Cardiac Failure 2006
Executive Summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline
HF America
Journal of Cardiac Failure 2006
Neurohormones and heart failure: the importance of aldosterone
K Odedra, A Ferro
International Journal of Clinical Practice 2006
Critical Heart Disease in Infants and Children
BA Fivush, AM Neu, R Parekh, LG Maxwell, LC Racusen, JR White, DG Nichols
Critical Heart Disease in Infants and Children 2006
Distinct Roles for the Kidney and Systemic Tissues in Blood Pressure Regulation by the Renin-Angiotensin System
Steven D Crowley, Susan B Gurley, Michael I Oliverio, A Kathy Pazmino, Robert Griffiths, Patrick J. Flannery, Robert F. Spurney, Hyung-Suk Kim, Oliver Smithies, Thu H Le & Thomas M Coffman
Journal of Clinical Investigation 2005
Role of Aldosterone Blockade in Heart Failure
B Pitt
Heart Failure Clinics 2005
The Role of Aldosterone Blockade in Patients with Heart Failure
B Pitt
Heart Failure Reviews 2005
Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system
Crowley SD, Gurley SB, Oliverio MI, Pazmino AK, Griffiths R, Flannery PJ, Spurney RF, Kim HS, Smithies O, Le TH, Coffman TM
Journal of Clinical Investigation 2005
Exploring type I angiotensin (AT1) receptor functions through gene targeting
SD Crowley, PL Tharaux, LP Audoly, TM Coffman
Acta Physiologica Scandinavica 2004
Angiotensin-converting enzyme inhibitors in the therapy of renal diseases
HP Lefebvre, PL Toutain
Journal of Veterinary Pharmacology and Therapeutics 2004
The regulation of aldosterone synthase expression
MH Bassett, PC White, WE Rainey
Molecular and Cellular Endocrinology 2004
Inhibition of RAAS—When is it too much?
P Navarro, R Moskowitz, TH le Jemtel
Current Heart Failure Reports 2004
Furosemide and the progression of left ventricular dysfunction in experimental heart failure
JM McCurley, SU Hanlon, S Wei, EF Wedam, M Michalski, MC Haigney
Journal of the American College of Cardiology 2004
Candesartan Prevents Myocardial Fibrosis during Progression of Congestive Heart Failure:
K Onishi, K Dohi, T Koji, K Funabiki, T Kitamura, K Imanaka-Yoshida, M Ito, T Nobori, T Nakano
Journal of Cardiovascular Pharmacology 2004
Combined angiotensin receptor blocker and ACE inhibitor on myocardial fibrosis and left ventricular stiffness in dogs with heart failure
K Funabiki, K Onishi, K Dohi, T Koji, K Imanaka-Yoshida, M Ito, H Wada, N Isaka, T Nobori, T Nakano
American journal of physiology. Heart and circulatory physiology 2004
Angiotensin Vol. I
T Unger, BA Schölkens
2004
Inhibition of RAAS—When is it too much?
P Navarro, R Moskowitz, TH Jemtel
Current Heart Failure Reports 2004
Diuretic use, progressive heart failure, and death in patients in the studies of left ventricular dysfunction (SOLVD)
M Domanski, J Norman, B Pitt, M Haigney, S Hanlon, E Peyster
Journal of the American College of Cardiology 2003
Encyclopedia of Hormones
RA DeFronzo, LJ Mandarino
Encyclopedia of Hormones 2003
The role of mineralocorticoid receptor antagonists in the treatment of cardiac failure
JW Funder
Expert Opinion on Investigational Drugs 2003
Mineralocorticoid receptor blockade: new insights into the mechanism of action in patients with cardiovascular disease
B Pitt, CT Stier, S Rajagopalan
Journal of Renin-Angiotensin-Aldosterone System 2003
New biology of aldosterone, and experimental studies on the selective aldosterone blocker eplerenone
JW Funder
American Heart Journal 2002
Impaired urine concentration and absence of tissue ACE: involvement of medullary transport proteins
JD Klein, DL Quach, JM Cole, K Disher, AK Mongiu, X Wang, KE Bernstein, JM Sands
American journal of physiology. Renal physiology 2002
Effects of AT 1A receptor deletion on blood pressure and sodium excretion during altered dietary salt intake
AJ Mangrum, RA Gomez, VF Norwood
American journal of physiology. Renal physiology 2002
Elevated Plasma Aldosterone Levels Despite Complete Inhibition of the Vascular Angiotensin-Converting Enzyme in Chronic Heart Failure
UP Jorde, T Vittorio, SD Katz, PC Colombo, F Latif, TH Jemtel
Circulation 2002
Aldosterone receptor blockade in the management of heart failure
Emiliano A Palmieri, Bernadette Biondi, Serafino Fazio
Heart Failure Reviews 2002
Progression and potential regression of glomerulosclerosis
AB Fogo
Kidney International 2001
Aldosterone in Congestive Heart Failure
KT Weber
New England Journal of Medicine 2001
ANGIOTENSIN RECEPTOR BLOCKERS AND ALDOSTERONE ANTAGONISTS IN CHRONIC HEART FAILURE
AB Miller, P Srivastava
Cardiology Clinics 2001
The combination ace-inhibitors plus canreonate in patients with anterior myocardial infarction: safety and tolerability study
PD Pasquale, V Alessi, O Barberi, A Scandurra, V Bucca, G Maringhini, S Scalzo, S Paterna
International Journal of Cardiology 2001
Review: Gene targeting studies of angiotensin II type 1 (AT1) receptors
TM Coffman, LP Audoly, MI Oliverio
Journal of Renin-Angiotensin-Aldosterone System 2001
Hyperkalemia, Renal Failure, and Converting-Enzyme Inhibition: An Overrated Connection
NH García, ST Baigorria, LI Juncos
Hypertension 2001
Eplerenone, a new mineralocorticoid antagonist:in vitro and in vivo studies
JW Funder
Current Opinion in Endocrinology & Diabetes 2000
Mineralocorticoid receptor knockout mice: Lessons on Na+ metabolism
S Berger, M Bleich, W Schmid, R Greger, G Schütz
Kidney International 2000
Evolution and Pathophysiology of Chronic Systolic Heart Failure
BE Bleske
Pharmacotherapy 2000
Insights into the Functions of Type 1 (AT1) Angiotensin II Receptors Provided by Gene Targeting
LP Audoly, MI Oliverio, TM Coffman
Trends in Endocrinology & Metabolism 2000
An intact renin – angiotensin system is a prerequisite for normal renal development
G Guron, P Friberg
Journal of Hypertension 2000
Aldosterone and the Heart
M Young, JW Funder
Trends in Endocrinology & Metabolism 2000
HFSA Guidelines for Management of Patients With Heart Failure Caused by Left Ventricular Systolic Dysfunction—Pharmacological Approaches
KF Adams, KL Baughman, WG Dec, U Elkayam, AD Forker, M Gheorghiade, D Hermann, MA Konstam, P Liu, BM Massie, JH Patterson, MA Silver, LW Stevenson, AM Feldman, JN Cohn, GS Francis, B Greenberg, MA Konstam, C Leier, BH Lorell, M Packer, B Pitt, MA Silver, E Sonnenblick, J Strobeck, R Walsh, S Yusuf
Pharmacotherapy 2000
The Role of the Renin-Angiotensin-Aldosterone System in the Management of Heart Failure
JE Rodgers, JH Patterson
Pharmacotherapy 2000
Angiotensin receptors: What is new?
I Ichikawa
American Journal of Kidney Diseases 2000
Insights derived from ACE knockout mice
J Cole, D Ertoy, KE Bernstein
Journal of Renin-Angiotensin-Aldosterone System 2000
Captopril Effects on the Rat Adrenal Cortex
D Pignatelli, M Maia, MJ Bento, S Sousa, ME Azevedo, MM Magalhaes, MC Magalhaes, GP Vinson
Endocrine Research 2000
Renal physiology of the mouse
P Meneton, I Ichikawa, T Inagami, J Schnermann
American journal of physiology. Renal physiology 2000
Regulation of Sodium Balance and Blood Pressure by the AT 1A Receptor for Angiotensin II
MI Oliverio, CF Best, O Smithies, TM Coffman
Hypertension 2000
Role of Dietary Potassium in the Hyperaldosteronism and Hypertension of the Remnant Kidney Model
HN Ibrahim, TH Hostetter
Journal of the American Society of Nephrology : JASN 2000
General overview of mineralocorticoid hormone action
MK Agarwal, M Mirshahi
Pharmacology & Therapeutics 1999
ROLE OF cAMP IN THE EFFECTS OF K+ ON THE STEROIDOGENESIS OF ZONA GLOMERULOSA CELLS
J Tait, S Tait
Clinical and Experimental Pharmacology and Physiology 1999
New insights into the renin-angiotensin system and hypertensive renal disease
AB Fogo
Current Hypertension Reports 1999
Adrenal zonation: clues from 11β-hydroxylase and aldosterone synthase
WE Rainey
Molecular and Cellular Endocrinology 1999
HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches
HF America
Journal of Cardiac Failure 1999
Aldosterone and Spironolactone in Heart Failure
KT Weber
New England Journal of Medicine 1999
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
B Pitt, F Zannad, WJ Remme, R Cody, A Castaigne, A Perez, J Palensky, J Wittes
New England Journal of Medicine 1999
Mechanism of Cardiac Fibrosis by Angiotensin
T Matsusaka, H Katori, T Homma, I Ichikawa
Trends in Cardiovascular Medicine 1999
Control of adrenal cell proliferation by AT 1 receptors in response to angiotensin II and low-sodium diet
PE McEwan, GP Vinson, CJ Kenyon
American journal of physiology. Endocrinology and metabolism 1999
Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes
S Tsuchida, T Matsusaka, X Chen, S Okubo, F Niimura, H Nishimura, A Fogo, H Utsunomiya, T Inagami, I Ichikawa
Journal of Clinical Investigation 1998
Hypertension
P Hamet, Z Pausova, V Adarichev, K Adaricheva, J Tremblay
Journal of Hypertension 1998
Endocrinological abnormalities in angiotensinogen-gene knockout mice
S Umemura, M Kihara, Y Sumida, M Yabana, T Ishigami, K Tamura, N Nyui, K Hibi, K Murakami, A Fukamizu, M Ishii
Journal of Hypertension 1998
Genetic deficiency of angiotensinogen produces an impaired urine concentrating ability in mice
M Kihara, S Umemura, Y Sumida, N Yokoyama, M Yabana, N Nyui, K Tamura, K Murakami, A Fukamizu, M Ishii
Kidney International 1998
Endocrinology of Cardiovascular Function
ER Levin, JL Nadler
1998
Primary Aldosteronism
AJ Hellem
Acta Medica Scandinavica 1956

← Previous 1 2 3 4 5 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 clinical guideline sources
28 readers on Mendeley
See more details